Compare Bristol-Myers Squibb Co (BMY) vs Toyota Motor Corp (TM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs Toyota Motor Corp — how do they compare? Bristol-Myers Squibb Co trades at $63.41 (market cap $129.94B), while Toyota Motor Corp trades at $188.35 (market cap $221.79B). The key difference: Toyota Motor Corp is the larger of the two by market cap, and Bristol-Myers Squibb Co pays the higher dividend (3.96%). Which is the better fit depends on your goals.
| BMY | TM | |
|---|---|---|
Market Cap | $129.94B | $221.79B |
Sector | Health | Consumer Cyclical |
52-Week High | $65.89 | $248.29 |
52-Week Low | $42.60 | $166.50 |
Enterprise Value | $163.92B | $414.06B |
Dividend Yield | 3.96% | 3.3% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About Toyota Motor Corp
Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.
Read more on TM →
